The minimum dose of acarbose suppresses triglyceride concentration in remnant-like particles from fasted diabetic subjects.
Yoshino
G
G
Furukawa
S
S
Hirano
T
T
Naito
H
H
Kazumi
T
T
Urayama
T
T
D020909:Acarbose; D001053:Apolipoproteins / Q000097:blood / Q000378:metabolism; D001786:Blood Glucose / Q000187:drug effects; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D003327:Coronary Disease / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005215:Fasting; D005260:Female; D005959:Glucosidases / Q000037:antagonists & inhibitors; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood / Q000378:metabolism*; D014312:Trisaccharides / Q000494:pharmacology*
D020909:Acarbose; D001053:Apolipoproteins; D001786:Blood Glucose; D002784:Cholesterol; D004791:Enzyme Inhibitors; D005959:Glucosidases; D006442:Glycated Hemoglobin; D014280:Triglycerides; D014312:Trisaccharides